Cécile Pierre‐Eugène

1.3k total citations
17 papers, 427 citations indexed

About

Cécile Pierre‐Eugène is a scholar working on Molecular Biology, Neurology and Surgery. According to data from OpenAlex, Cécile Pierre‐Eugène has authored 17 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Neurology and 3 papers in Surgery. Recurrent topics in Cécile Pierre‐Eugène's work include Neuroblastoma Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Lung Cancer Research Studies (3 papers). Cécile Pierre‐Eugène is often cited by papers focused on Neuroblastoma Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Lung Cancer Research Studies (3 papers). Cécile Pierre‐Eugène collaborates with scholars based in France, Germany and Austria. Cécile Pierre‐Eugène's co-authors include Tarik Issad, Christiane S. Hampe, Patrick Pagésy, Isabelle Janoueix‐Lerosey, Olivier Delattre, Yann Fardini, Elodie Masson, Caroline Louis‐Brennetot, Marion Neuillé and Thierry N’Tumba-Byn and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Cancer Research.

In The Last Decade

Cécile Pierre‐Eugène

16 papers receiving 424 citations

Peers

Countries citing papers authored by Cécile Pierre‐Eugène

Since Specialization

Citations

This map shows the geographic impact of Cécile Pierre‐Eugène's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Pierre‐Eugène with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Pierre‐Eugène more than expected).

Fields of papers citing papers by Cécile Pierre‐Eugène

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Pierre‐Eugène. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Pierre‐Eugène. The network helps show where Cécile Pierre‐Eugène may publish in the future.

Co-authorship network of co-authors of Cécile Pierre‐Eugène

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Pierre‐Eugène. A scholar is included among the top collaborators of Cécile Pierre‐Eugène based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Pierre‐Eugène. Cécile Pierre‐Eugène is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells 2022 ·Cancers ·(unknown), Caroline Louis‐Brennetot, Cécile Pierre‐Eugène, Sylvain Baulande, Virginie Raynal, Amira Kramdi, Igor Adameyko, Uwe Ernsberger, Thomas Deller, Olivier Delattre, Isabelle Janoueix‐Lerosey, Hermann Rohrer	0
2	Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells 2021 ·Cancer Research ·Anna Solé, Sandrine Grossetête, (unknown), Loélia Babin, Sakina Zaïdi, Patrick Revy, Benjamin Renouf, Anne De Cian, Carine Giovannangeli, Cécile Pierre‐Eugène, Isabelle Janoueix‐Lerosey, Lucile Couronné, Sophie Kaltenbach, Mark Tomishima, Maria Jasin, Thomas G. P. Grünewald, Olivier Delattre, Didier Surdez, Erika Brunet	41
3	ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations 2019 ·Oncotarget ·Simon Durand, Cécile Pierre‐Eugène, Olivier Mirabeau, Caroline Louis‐Brennetot, Valérie Combaret, Léo Colmet‐Daage, (unknown), Angela Bellini, Estelle Daudigeos‐Dubus, Virginie Raynal, Gudrun Schleiermacher, Sylvain Baulande, Olivier Delattre, Isabelle Janoueix‐Lerosey	5
4	Activated ALK signals through the ERK–ETV5–RET pathway to drive neuroblastoma oncogenesis 2018 ·Oncogene ·Lucille Lopez‐Delisle, Cécile Pierre‐Eugène, Caroline Louis‐Brennetot, Didier Surdez, Virginie Raynal, Sylvain Baulande, Valentina Boeva, Sandrine Grossetête-Lalami, Valérie Combaret, Michel Peuchmaur, Olivier Delattre, Isabelle Janoueix‐Lerosey	38
5	Identification of insulin-sensitizing molecules acting by disrupting the interaction between the Insulin Receptor and Grb14 2017 ·Scientific Reports ·(unknown), Christiane S. Hampe, (unknown), (unknown), Cécile Pierre‐Eugène, Maria A. Miteva, Bruno O. Villoutreix, (unknown), David J. Aitken, Tarik Issad, Anne‐Françoise Burnol	5
6	APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis 2016 ·Oncotarget ·Anna Raimbault, (unknown), Cécile Pierre‐Eugène, Alexandra Rouquette, (unknown), Lise Willems, Nicolas Chapuis, Stéphanie Mathis, (unknown), Harald Fricke, Olivier Kosmider, Valérie Bardet, Michaëla Fontenay	10
7	Effect of insulin analogues on phosphatidyl inositol-3 kinase/Akt signalling in INS-1 rat pancreatic derivedβ-cells 2015 ·Archives of Physiology and Biochemistry ·Patrick Pagésy, Yann Fardini, (unknown), (unknown), Cécile Pierre‐Eugène, Norbert Tennagels, Tarik Issad	4
8	Lin28B and Let-7 in the Control of Sympathetic Neurogenesis and Neuroblastoma Development 2015 ·Journal of Neuroscience ·(unknown), Jutta Stubbusch, (unknown), Marco Krämer, Thomas Deller, Cécile Pierre‐Eugène, Isabelle Janoueix‐Lerosey, Olivier Delattre, Uwe Ernsberger, Johannes H. Schulte, Hermann Rohrer	26
9	Development of a Human Breast-Cancer Derived Cell Line Stably Expressing a Bioluminescence Resonance Energy Transfer (BRET)-Based Phosphatidyl Inositol-3 Phosphate (PIP3) Biosensor 2014 ·PLoS ONE ·Mei-Shiue Kuo, (unknown), Cécile Pierre‐Eugène, Tarik Issad	12
10	Hyperactivation of Alk induces neonatal lethality in knock-in AlkF1178L mice 2014 ·Oncotarget ·Lucille Lopez‐Delisle, Cécile Pierre‐Eugène, Evelyne Bloch‐Gallego, Marie‐Christine Birling, Jean‐Loup Duband, Estelle Durand, (unknown), Boris Matrot, Tania Sorg, Michel Huerre, Hamid Méziane, Michel J. Roux, Marie‐France Champy, Jorge Gallego, Olivier Delattre, Isabelle Janoueix‐Lerosey	4
11	Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma 2014 ·Oncotarget ·Alex Cazes, Lucille Lopez‐Delisle, Konstantina Tsarovina, Cécile Pierre‐Eugène, Katleen De Preter, Michel Peuchmaur, Nicolás André, C. Provost, Caroline Louis‐Brennetot, Romain Daveau, Candy Kumps, Ilaria Cascone, Gudrun Schleiermacher, Aurélie Prignon, Frank Speleman, Hermann Rohrer, Olivier Delattre, Isabelle Janoueix‐Lerosey	73
12	O-GlcNAcylation-Inducing Treatments Inhibit Estrogen Receptor α Expression and Confer Resistance to 4-OH-Tamoxifen in Human Breast Cancer-Derived MCF-7 Cells 2013 ·PLoS ONE ·Shahzina Kanwal, Yann Fardini, Patrick Pagésy, Thierry N’Tumba-Byn, Cécile Pierre‐Eugène, Elodie Masson, Christiane S. Hampe, Tarik Issad	58
13	Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis 2013 ·PLoS ONE ·Valentina Boeva, Stéphanie Jouannet, Romain Daveau, Valérie Combaret, Cécile Pierre‐Eugène, Alex Cazes, Caroline Louis‐Brennetot, Gudrun Schleiermacher, Sandrine Ferrand, Gaëlle Pierron, Alban Lermine, Thomas Rio Frio, Virginie Raynal, Gilles Vassal, Emmanuel Barillot, Olivier Delattre, Isabelle Janoueix‐Lerosey	28
14	O ‐GlcNAcylation of FoxO1 in pancreatic β cells promotes Akt inhibition through an IGFBP1‐mediated autocrine mechanism 2013 ·The FASEB Journal ·Yann Fardini, Elodie Masson, (unknown), (unknown), (unknown), Cécile Pierre‐Eugène, (unknown), Tarik Issad	29
15	Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2 2012 ·PLoS ONE ·Cécile Pierre‐Eugène, Patrick Pagésy, (unknown), Marion Neuillé, Georg Tschank, Norbert Tennagels, Christiane S. Hampe, Tarik Issad	55
16	p-ERK1/2 is a predictive factor of response to erythropoiesis-stimulating agents in low/int-1 myelodysplastic syndromes 2010 ·Haematologica ·Emilie Frisan, Patrycja Pawlikowska, Cécile Pierre‐Eugène, Vivian Viallon, Laure Gibault, Sophie Park, (unknown), François Dreyfus, Françoise Porteu, Michaëla Fontenay	21
17	Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum 2008 ·Leukemia ·Emmanuel Gyan, Emilie Frisan, Odile Beyne‐Rauzy, Jean‐Christophe Deschemin, Cécile Pierre‐Eugène, Clotilde Randriamampita, Anne Dubart‐Kupperschmitt, Carmen Garrido, François Dreyfus, Patrick Mayeux, C. Lacombe, Éric Solary, Michaëla Fontenay	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact